04:04 AM EST, 11/11/2025 (MT Newswires) -- Jacob Steven Leach, President & Chief Operating Officer, on November 10, 2025, executed a purchase for 18,200 shares in Dexcom ( DXCM ) for $1,001,702. Following the Form 4 filing with the SEC, Leach has control over a total of 378,993 common shares of the company, with 331,697 shares held directly and 47,296 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1093557/000109355725000284/xslF345X05/wk-form4_1762819985.xml